Abstract
OBJECTIVE--To compare present pacing practice with the recommendations recently published by the British Pacing and Electrophysiology Group and to assess the increase in annual budget required to implement these recommendations in a regional cardiothoracic unit. DESIGN--Retrospective analysis of pacemaker implantation for 1991 with calculation of the costs required to implement the group's recommendations based on average 1991 costs of the types of pacing generators and electrode leads used. SETTING--Regional cardiothoracic unit for South West Thames Health Authority. PATIENTS--433 consecutive patients receiving permanent pacemaker generators: 76 (18%) with sinus node disease; 270 (62%) with atrioventricular block; 25 (6%) with both sinus node disease and atrioventricular block; 59 (14%) with chronic atrial fibrillation and atrioventricular block; and 3 (1%) with carotid sinus or malignant vasovagal syndromes. RESULTS--Only 102 (24%) patients received pacemaker generators recommended by the British Pacing and Electrophysiology Group; however, 355 (82%) patients were older than 65 years, and 264 (61%) were aged 75 or over. The cost of hardware for pacing was 462,885 pounds. Using generators as recommended would have cost 810,525 pounds for "optimal" systems (an increase of 75%) and 710,750 pounds for "alternative" systems (an increase of 54%). These increases would have been considerably reduced by limiting the use of sophisticated pacing to younger patients (aged under 75). Further savings could be made by using the least expensive pacing models available. CONCLUSIONS--Implementing these recommendations should reduce morbidity related to bradyarrhythmia but will lead to major increases in pacing costs. Age and patients' expected activity may be used to select simple pacing systems and thus to contain cost. More research is needed to determine which patient groups will benefit most from complex pacing systems.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahsan A. Indications for pacing. Lancet. 1992 Jan 4;339(8784):62–62. doi: 10.1016/0140-6736(92)90191-5. [DOI] [PubMed] [Google Scholar]
- Fitzpatrick A., Theodorakis G., Vardas P., Kenny R. A., Travill C. M., Ingram A., Sutton R. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991 Mar;12(3):389–394. doi: 10.1093/oxfordjournals.eurheartj.a059906. [DOI] [PubMed] [Google Scholar]
- Rosenqvist M., Brandt J., Schüller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988 Jul;116(1 Pt 1):16–22. doi: 10.1016/0002-8703(88)90244-x. [DOI] [PubMed] [Google Scholar]
- Sasaki Y., Shimotori M., Akahane K., Yonekura H., Hirano K., Endoh R., Koike S., Kawa S., Furuta S., Homma T. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol. 1988 Nov;11(11 Pt 1):1575–1583. doi: 10.1111/j.1540-8159.1988.tb06277.x. [DOI] [PubMed] [Google Scholar]
- Schüller H., Brandt J. The pacemaker syndrome: old and new causes. Clin Cardiol. 1991 Apr;14(4):336–340. doi: 10.1002/clc.4960140410. [DOI] [PubMed] [Google Scholar]
- Zanini R., Facchinetti A. I., Gallo G., Cazzamalli L., Bonandi L., Dei Cas L. Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing. Pacing Clin Electrophysiol. 1990 Dec;13(12 Pt 2):2076–2079. doi: 10.1111/j.1540-8159.1990.tb06945.x. [DOI] [PubMed] [Google Scholar]